Morphisec

Morphisec was founded in 2014 out of the JVP Cyber Labs incubator and Ben-Gurion University of the Negev. The company is privately held and headquartered in Beer Sheva, Israel, with a United States presence based in Boston.

The core technology is based on Moving Target Defense (MTD). Instead of relying on signature matching or behavioral analysis, MTD randomizes the application memory and runtime environment. This approach blocks zero-day attacks, fileless malware, and in-memory exploits by making the attack surface unpredictable to the malware. The software is deployed primarily on enterprise endpoints, servers, and virtual desktop infrastructure (VDI).

Morphisec's primary offerings target endpoint and server environments. The product is frequently deployed as a preventative layer alongside Microsoft Defender, upgrading standard OS-level security without the CPU and memory overhead typically associated with full Endpoint Detection and Response (EDR) agents.

Morphisec operates in the endpoint security space (EPP). Rather than competing directly against heavy EDR platforms like SentinelOne or CrowdStrike to analyze post-breach behavior, it focuses strictly on pre-execution prevention. The company relies on its patented MTD approach to differentiate itself from traditional antivirus vendors.

The company's primary R&D center is located in the Gav-Yam Negev Advanced Technologies Park in Beer Sheva. This location stems from its origins at Ben-Gurion University. Key early investors include Jerusalem Venture Partners (JVP). The Israel office houses the core engineering, threat intelligence, and product teams.